0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Clinically Relevant Resistance in Cancer Chemotherapy (Paperback, Softcover reprint of the original 1st ed. 2002) Loot Price: R2,821
Discovery Miles 28 210
Clinically Relevant Resistance in Cancer Chemotherapy (Paperback, Softcover reprint of the original 1st ed. 2002): Borje...

Clinically Relevant Resistance in Cancer Chemotherapy (Paperback, Softcover reprint of the original 1st ed. 2002)

Borje Andersson, David Murray

Series: Cancer Treatment and Research, 112

 (sign in to rate)
Loot Price R2,821 Discovery Miles 28 210 | Repayment Terms: R264 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Donate to Against Period Poverty

Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Cancer Treatment and Research, 112
Release date: October 2012
First published: 2002
Editors: Borje Andersson • David Murray
Dimensions: 235 x 155 x 21mm (L x W x T)
Format: Paperback
Pages: 380
Edition: Softcover reprint of the original 1st ed. 2002
ISBN-13: 978-1-4613-5428-4
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4613-5428-5
Barcode: 9781461354284

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners